| Serial Number | 97170031 |
| Word Mark | ISOMORPHIC LABS |
| Filing Date | Monday, December 13, 2021 |
| Status | 690 - NOTICE OF ALLOWANCE - CANCELLED |
| Status Date | Thursday, January 30, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, September 26, 2023 |
| Goods and Services | Downloadable computer software using artificial intelligence, machine learning, deep learning, and reinforcement learning for predicting protein structure, discovering pharmaceutical drugs, and developing pharmaceutical products; downloadable computer software, computer programs and computer software algorithms for manipulating received or inputted data generated in a virtual space in connection with artificial intelligence methods, natural language processing, natural language understanding, dialog systems, voice and speech recognition and text to speech systems, natural language human-machine interfaces, and predictive assistance technologies for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development |
| NOT AVAILABLE | "LABS" |
| Goods and Services | Software as a service (SAAS) services featuring software using artificial intelligence, machine learning, deep learning, and reinforcement learning for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; advanced product research, design and development in the field of artificial intelligence for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; research and development in the fields of artificial intelligence, machine learning, deep learning, and reinforcement learning technologies for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; technology research in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; providing online, non-downloadable computer software platforms using artificial intelligence, machine earning, deep learning, and reinforcement learning for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; testing of computing methods, computer software algorithms, computer software, and computer hardware for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; scientific, pharmaceutical, and medical research; scientific research in the field of computer software using artificial intelligence, machine learning, deep learning, and reinforcement learning for medical research, pharmaceutical research, protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; product research and development; medical, pharmaceutical, and scientific research in the field of protein structure prediction, pharmaceutical drug discovery, pharmaceutical product development, and computational biology; scientific and technological services, namely, scientific research in the fields of analytics and data mining, data analysis, data transformation, data visualization, statistical analysis, artificial intelligence, machine learning and virtual reality, science, chemistry, physics, biology and scientific research, all for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; computer aided data analysis for scientific research purposes in the fields of artificial intelligence, machine learning, deep learning, reinforcement learning, building neural networks, data tree search, high performance computing, distributed computing, cloud computing, analytics and data mining, virtual reality, augmented reality, chemistry, physics, biology, all for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; computer modelling services; scientific services for the analysis of organic compounds; drug discovery services |
| International Class | 009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus. |
| US Class Codes | 021, 023, 026, 036, 038 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, December 17, 2021 |
| Primary Code | 009 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, December 17, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Isomorphic Labs Limited |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | London EC2M4RB GB |
| Party Name | Isomorphic Labs Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | London EC4V6JA GB |
| Event Date | Event Description |
| Thursday, December 16, 2021 | NEW APPLICATION ENTERED |
| Friday, December 17, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, September 20, 2022 | ASSIGNED TO EXAMINER |
| Wednesday, September 21, 2022 | NON-FINAL ACTION WRITTEN |
| Wednesday, September 21, 2022 | NON-FINAL ACTION E-MAILED |
| Wednesday, September 21, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, March 21, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, March 21, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, March 22, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, May 3, 2023 | ASSIGNED TO EXAMINER |
| Thursday, May 25, 2023 | FINAL REFUSAL WRITTEN |
| Thursday, May 25, 2023 | FINAL REFUSAL E-MAILED |
| Thursday, May 25, 2023 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Monday, August 14, 2023 | EXAMINERS AMENDMENT -WRITTEN |
| Monday, August 14, 2023 | EXAMINERS AMENDMENT E-MAILED |
| Monday, August 14, 2023 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Monday, August 14, 2023 | EXAMINER'S AMENDMENT ENTERED |
| Monday, August 14, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, August 18, 2023 | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |
| Monday, August 21, 2023 | ELECTRONIC RECORD REVIEW COMPLETE |
| Wednesday, September 6, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, September 26, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, September 26, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, November 21, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Friday, April 19, 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Friday, April 19, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Friday, April 19, 2024 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Friday, May 17, 2024 | SOU EXTENSION 1 GRANTED |
| Friday, May 17, 2024 | SOU EXTENSION 1 FILED |
| Friday, May 17, 2024 | SOU TEAS EXTENSION RECEIVED |
| Saturday, May 18, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, November 19, 2024 | SOU EXTENSION 2 FILED |
| Tuesday, November 19, 2024 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, November 20, 2024 | TEAS PETITION TO AMEND BASIS RECEIVED |
| Monday, January 6, 2025 | ASSIGNED TO PETITION STAFF |
| Saturday, January 11, 2025 | SOU EXTENSION 2 GRANTED |
| Saturday, January 11, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, January 27, 2025 | PETITION TO DIRECTOR - CHANGE BASIS - GRANTED |
| Monday, January 27, 2025 | JURISDICTION RESTORED TO EXAMINING ATTORNEY |
| Thursday, January 30, 2025 | NOTICE OF ALLOWANCE CANCELLED |